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The Development of Contraceptive Methods
for Captive Wildlife
Cheryl S. Asa

Abstract: Contraception has become critical in managing
zoo populations, both to limit production of surplus animals
and to promote genetic health. One role of the
Contraception Advisory Group, formed in 1989, is to
coordinate research to develop new contraceptive methods.
Because melengestrol acetate (MGA) implants, which have
been used by zoos for almost 20 years, recently have been
associated with uterine pathology in felids, several new
contraceptive techniques are being evaluated. These
include other steroid hormone formulations, such as the
birth control pill Depo-Provers,@ the Norplanm implant, and
MGA added to feed; bisdiamine, an oral male contraceptive;
zona pellucida (ZP) vaccine; and vas plugs. Bisdiamine
reversibly blocked spermatogenesis while sparing
testosterone in its first test in gray wolves. ZP vaccine has

been effective in preventing births in a variety of species of
hoofstock, primates, and carnivores; however, long-term
deleterious effects on the ovaries have been found in some
controlled trials. Injectable vas plugs that conform to the
shape of the vas make it possible to successfullytreat a
wide variety of species; reversal trials are currently
underwav. As research efforts continue, we hODe to ex~and
our collaborations with scientists working on contracepiive
devel0Dment for humans. com~anionanimals and wildlife.
to better make use of the limited resources available for
these investigations.
Keywords: contraception, captive animals, zoo, vas plugs,
bisdiamine, indenopyridine, zona pellucida vaccine, GnRH
agonist, LHRH vaccine

Introduction
The modern zoo now faces the consequences of
becoming too successful at breeding and maintaining
the animals in its care. Advances in husbandry,
nutrition, and medicine have resulted in more births
and longer lives for most captive species. The major
benefit of this success is that these captive populations can be self-perpetuating and not dependent on
importation of animals from the wild. However, due to
limited space and resources, zoos cannot allow
uncontrolled reproduction.
In addition, zoos give high priority to proper
genetic management, that is, reduction of inbreeding
and balanced genetic representation of the founders
of captive populations. Both genetic management and
limiting production of surplus animals are being
accomplished through contraception.
Although physical separation of males and
females can prevent unwanted conceptions, most
zoos consider this an undesirable measure. Not only
can such an arrangement be stressful for species in
which males and females typically associate, lone
animals present an unnatural view of that species to
the visiting public. A primary mission of zoos is
education, a mission that is better served by maintaining animals in social groupings which are as representative as possible of the organization that would occur
in the wild.

In recognition of the importance of contraception
in responsible animal management, the American
Association of Zoos and Aquariums approved formation of the Contraception Advisory Group in 1989.
Composed of zoo curators, veterinarians, and reproductive physiologists, the group surveys the use of
contraception in zoos for inclusion in a computerized
data base, advises zoo personnel, and initiates and
coordinates research into alternative methods.
The International Wildlife Contraception Database, housed at the St. Louis Zoo, was developed and
is maintained by Ingrid Porton and Betsy Hornbeck of
the Contraception Advisory Group. Begun in 1990
and updated from yearly surveys, it currently contains
more than 2,000 complete records on 184 species and
serves as a resource for zoo animal managers and for
researchers.
Contraception of captive wildlife in zoos began in
the mid-1970's. After preliminary tests with lions and
tigers (Seal et al. 1976, Seal and Plotka 1978) comparing medroxyprogesterone acetate (Provera,BThe
Upjohn Co., Kalamazoo, MI, USA) and melengestrol
acetate (MGA, also Upjohn), MGA in silicone implant
form was selected as the more suitable. Of the more
than 80 percent of North American zoos that reported
using contraception (Porton et al. 1990), most use the
MGA implant.
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However, concern has arisen about possible
pathology in progestin-treated carnivores (Kollias
1988, Kollias et al. 1984) because deleterious effects
have been associated with progestin use in domestic
dogs and cats (reviewed in Asa and Porton 1991, Asa
et al. 1996). Indeed, histological examination of uteri
from MGA-treated felids has revealed significantly
more pathology than those from untreated felids
(Munson and Mason 1991).
No comparable effects are expected in primates,
based on the extensive studies that have been conducted in laboratory primates, as well as decades of
progestin administration to human females. In general, birth control methods that have been approved
for human use should be safe and effective for nonhuman primates. Birth control pills (combination progestin and estrogen, various formulations commercially
available), Depo-Provera, Norplant (levonorgestrel
implant system, Wyeth-Ayerst, Philadelphia, PA,
USA), and intrauterine devices have been used in
primates, especially in the great apes (Porton et al.
1990). However, few data exist on progestin effects in
ungulates and other mammals.
A number of research trials are under way to
evaluate new approaches with the hope of providing a
broader selection of contraceptives, especially alternatives to the progestin-based formulations for carnivores.
These include vas plugs, the antispermatogenic compounds bisdiamine and indenopyridine, and short-term
Depo-Proverafor seasonal breeders. Additional work is
focusing on specific aspects of MGA treatment. For a
discussion of the progress of zona pellucida trials in
zoos, see Kirkpatrick et al., this volume.

Melengestrol Acetate
As mentioned, MGA is the most frequently used
contraceptive for captive mammals. MGA is incorporated into silicone rods by E. D. Plotka (Marshfield
Medical Research Foundation, Marshfield, WI) and
distributed to zoos throughout the world. When
inserted subcutaneously, the implants provide effective contraception for at least 2 years (Porton et al.
1990). The only side effect noted in primates has

been weight gain (Portugal and Asa 1995), which is
also common in human females treated with
progestins.
Because of concern about possible effects on
social behavior, a study was conducted with a troop of
hamadryas baboons (Papio hamadryas) at the St.
Louis Zoo (Portugal and Asa 1995). Administration of
MGA was not associated with social disruption.
Treated females were involved in fewer affiliative
interactions, but there was no increase in aggression
compared to control animals.
Although MGA implants have been effective in a
wide range of monkeys and apes, some New World
primate species have proven resistant. Because they
have naturally high levels of endogenous steroids,
these species may require larger exogenous doses to
achieve contraception. Research is being conducted
to test this hypothesis (E. Plotka, pers. comm.).
Recognizing that individual capture and immobilization for implant insertion may be inadvisable in
some situations, Bronx Zoo veterinarians (B. Raphael,
pers. comm.) have tested adding MGA to feed for
herds of antelope and deer. Although this procedure
is generally successful, drawbacks include contraceptive failure in some subordinate animals that apparently did not ingest a sufficient dose and alteration of
the antler cycle in male barasinga (Cervus duvauceli).
Pathological effects of MGA and related
progestins are being investigated by Linda Munson
(University of Tennessee, Knoxville). Early work
concentrated on reproductive tracts of felids (Munson
and Mason 1991), and research is now extending to
other carnivores and primates. In general, progestins
have been found to stimulate growth of the uterine
lining of felids and canids, resulting in hyperplasia,
pyometra, and neoplasia (reviewed in Asa and Porton
1991). Effects of dosage, length of treatment, and age
during treatment are currently being studied.
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Depo-Provera
The belief that side effects can be minimized by a
shorter treatment period has created interest in the
progestin medroxyprogesterone acetate in its injectable, slow-release formulation. In particular, seasonal
breeders that are fertile for only part of the year might
benefit from progestin exposure for only that period,
as opposed to the continual, long-term exposure
imposed by an implant. An injection every 2-3 months
is thought to be preferable to the repeated surgical
procedures required for implant insertion and removal.
Doselresponse trials and evaluation of weight
gain have been conducted with ruffed lemurs (Varecia
variegata) and black lemurs (L. macaco) at the St.
Louis Zoo, in collaboration with the Henson-Robinson
and Metro Toronto zoos. Using vaginal cytology to
monitor suppression of cycles, researchers found the
minimum effective dose to be 5 mg per kilogram of
body weight. Pelage darkening in treated black lemur
females was an unexpected side effect, probably
related to the ability of this progestin to bind androgen
receptors (Labrie et al. 1987). (Black lemurs are
sexually dimorphic in color, with males having a black
and females a brown coat).
Depo-Provera also is being used in hippopotamuses (Choeropsis liberiensis), giraffes (Giraffa
camelopardus), sea lions (Zalophus californianus),
and gray seals (Halichoerus grypus), although not part
of controlled research projects. There is concern
about sea lions and seals, in particular, because they
are closely related to the carnivores and because they
have extensive fat stores that may absorb and hold
steroids, which are lipophilic. Fat stores may also
present a problem with hippos.

Norplant
Although no controlled studies have been published,
several zoos are using these implants, which contain
levonorgestrel, a synthetic progestin related to both
MGA and Provera. Its advantage over MGA is the
much thinner capsules, which can be inserted with a
trocar. Com~aredto the incision and sutures needed

for the MGA implants, the small puncture site attracts
less grooming and reduces the chance of loss.

Birth Control Pills
As with Norplant, some zoos opt to use oral birth
control pills, another product developed for the human
market. The willingness of many apes to take pills
placed in food treats dispenses with the need for
immobilization and insertion of an implant. The vast
majority of pills contain estrogen in combination with a
much lower dose of progestin than is present in the
progestin-only forms discussed above. Although this
combination does not significantly alter the associated
side effects for primates, it is not appropriate for
carnivores. Adding estrogen to progestin in formulations given to dogs exacerbates uterine pathology
(Teunissen 1952).

Megestrol Acetate
Another synthetic progestin-available as MegaceB
(Mead Johnson Laboratories, Evansville, IN, USA) or
OvabanB (Schering-Plough, Union, NJ, USA)-is
sometimes used as a contraceptive in domestic dogs
and cats. However, because of the attendant risk of
hyperplasia and pyometra, this synthetic it is not
recommended for more than two consecutive treatments.

Lupron Depot@
An agonist of GnRH (gonadotropin-releasing hormone
also called LHRH, luteinizing-hormone releasing
hormone), Lupron Depot (TAP Pharmaceuticals, North
Chicago, IL, USA) has been used in males of several
species in attempts to block spermatogenesis. Although
theoretically tenable, this approach has been unsuccessful due to incomplete suppression of sperm
production. Sperm numbers must be reduced below
the level required for fertilization for this to be an
effective contraceptive. Because the GnRH agonists
and antagonists block production of testosterone, they
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also can find application in suppression of aggression
in some individuals.

Bisdiamine

Lupron Depot also has been given to females to
suppress cyclicity. However, because agonists first
stimulate the endocrine cascade that results in ovulation, administration to induced ovulators, such as the
felids, may stimulate ovulation and pseudopregnancy
before suppressing cycles by negative feedback.

All the steroid hormone preparations in use in zoos
target the female. However, if prevention of reproduction is desired in polygynous social groups, it is more
efficient to treat the males than the females. The
bisdiamine WIN 18,446 (Sterling Winthrop,
Rensselaer, NY, USA) was tested in the early 1960's
as a birth control pill for men. It works by selectively
interfering with spermatogenesis but not testosterone
production. Although initial trials demonstrated the
drug to be effective, safe, and reversible, it was soon
discovered to interact with an enzyme that detoxifies
alcohol. Thus, men taking bisdiamine who then drank
alcohol became ill, making the compound unsuitable
for general marketing. Because we assume that we
can prevent alcohol consumption in captive animals,
bisdiamine may be a feasible contraceptive alternative
for this application.

Although analogues show promise in providing
the equivalent of reversible chemical castrations, their
current cost prohibits for widespread use. Long-term
delivery also is a problem. Because these compounds
are not orally active and do not follow the same
diffusion dynamics as steroids, traditional delivery
methods such as silicone implants have not been
effective. Both a silicone elastomer matrix and a
reservoir system are being tested (Vickery et al.
1989).

LHRH Vaccine
Immunization against LHRH can provide contraception
for both males and females (Fraser 1986). LHRH
initiates the cascade of hormonal events that results in
testosterone and sperm production in males and in
production of estrogen and progesterone and ovulation in females. Because this vaccination would
accomplish the equivalent of a reversible chemical
castration, it can be especially appropriate for males
to suppress testosterone and thus aggression and for
female carnivores to completely suppress secretion of
progesterone. Vaxstrate, an LHRH vaccine that is
commercially available in Australia (Arthur Webster
Pty. Ltd., New South Wales, Australia) for domestic
cows (Hoskinson et al. 1990), has also been used with
success in some exotic species at the Western Plains
and Perth zoos (D. Blyde and S. Haigh, pers. comm.).
In this country, both The Population Council in New
York and Colorado State University are developing
LHRH vaccines.

The first test of bisdiamine in a wildlife species
was conducted with a captive colony of gray wolves
(Asa et al. 1995). Daily administration in ground meat
at a dose of 200 mglkg suppressed spermatogenesis
without affecting mating behavior. In the subsequent
breeding season, semen samples of the previously
treated males were comparable to those of controls,
confirming reversibility.

lndenopyridine
This drug (Research Triangle Institute, Research
Triangle Park, NC, USA) is similar to bisdiamine in
that it is orally active and blocks sperm production
without interrupting testosterone secretion. To date, it
has been tested only in rodents (Fail et al. 1991,
Gurtler and Donatsch 1979, Hodel and Suter 1978),
so the extent of its efficacy and safety has not been
adequately determined. A dose response trial with
domestic cats, as a model for exotic felids, is currently
being conducted (Fail et al., unpubl.)
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Vas Plugs
L.J.D. Zaneveld and I investigated vas plugs. Silicone
injected into the vas deferens, the tube carrying sperm
from the testis, hardens to form a barrier that prevents
the passage of sperm. Plugs were placed in 59
mammals, including marsupials, felids, primates, and
ungulates, at 17 different zoos. Early use of the
preformed plug (Zaneveld et al. 1988), which is also in
clinical trials with humans, proved inadequate for the
range of vas sizes encountered in zoo animals. The
injectable plugs were successful in blocking passage
of sperm, but fertility was not restored after removal.
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